Phase Ⅱ Study of Combined Sintilimab and Anlotinib with Gemcitabine plus Cisplatin in Advanced Biliary Tract Cancer: Efficacy, Safety and Optimize DoseJingjing Li, Jieer Ying, Weijing Sun et al.|Research Square|2024Cited by 1